|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8516
|
|
pubmed:dateCreated |
1986-12-17
|
|
pubmed:abstractText |
A booster dose of hepatitis B vaccine was given to 143 children in whom hepatitis B had not developed 1 year after initial vaccination. Over the next six years the incidence of hepatitis B in this group was 1.5% per year compared with 11.5% per year in a similar group of unvaccinated children. In the first 4 years the protective efficacy of the vaccine was 100%, but during the 5th and 6th years it fell to 67%. For maximum protection a second booster is needed, 5 years after the first.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0140-6736
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1143-5
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:2877284-Carrier State,
pubmed-meshheading:2877284-Evaluation Studies as Topic,
pubmed-meshheading:2877284-Female,
pubmed-meshheading:2877284-Follow-Up Studies,
pubmed-meshheading:2877284-Hepatitis B,
pubmed-meshheading:2877284-Hepatitis B Antibodies,
pubmed-meshheading:2877284-Hepatitis B Vaccines,
pubmed-meshheading:2877284-Humans,
pubmed-meshheading:2877284-Immunization, Secondary,
pubmed-meshheading:2877284-Infant,
pubmed-meshheading:2877284-Male,
pubmed-meshheading:2877284-Senegal,
pubmed-meshheading:2877284-Time Factors,
pubmed-meshheading:2877284-Viral Hepatitis Vaccines
|
|
pubmed:year |
1986
|
|
pubmed:articleTitle |
Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal).
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
